Cargando…
Inhibition of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infectivity by peptides analogous to the viral spike protein
Severe acute respiratory syndrome-associated coronavirus (SARS-CoV) is the cause of an atypical pneumonia that affected Asia, North America and Europe in 2002–2003. The viral spike (S) glycoprotein is responsible for mediating receptor binding and membrane fusion. Recent studies have proposed that t...
Autores principales: | Sainz, Bruno, Mossel, Eric C., Gallaher, William R., Wimley, William C., Peters, C.J., Wilson, Russell B., Garry, Robert F. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2582734/ https://www.ncbi.nlm.nih.gov/pubmed/16616792 http://dx.doi.org/10.1016/j.virusres.2006.03.001 |
Ejemplares similares
-
Interferon-beta and interferon-gamma synergistically inhibit the replication of severe acute respiratory syndrome-associated coronavirus (SARS-CoV)
por: Sainz, Bruno, et al.
Publicado: (2004) -
Synergistic Inhibition of Sars-Coronavirus Replication by Type I and Type II IFN
por: Mossel, Eric C., et al.
Publicado: (2006) -
Peptide entry inhibitors of enveloped viruses: The importance of interfacial hydrophobicity()
por: Badani, Hussain, et al.
Publicado: (2014) -
Viroporin potential of the lentivirus lytic peptide (LLP) domains of the HIV-1 gp41 protein
por: Costin, Joshua M, et al.
Publicado: (2007) -
Modeling of the Ebola Virus Delta Peptide Reveals a Potential Lytic Sequence Motif
por: Gallaher, William R., et al.
Publicado: (2015)